The pharmaceutical industry seems besieged on all sides by declining R&D productivity, expiring patents and relentless downward pricing pressure. One effect of this onslaught has been an upsurge in the level of consolidation as industry players attempt to cut costs, expand research pipelines and lengthen geographic reach.
12-Jan-2012 - Charles River’s CEO has reiterated the importance of integrating its research models and preclinical units but refused to discuss takeover reports.
11-Jan-2012 - Major CRO consolidation will slow down in 2012 after the big wave of deals last year, the CEO of Icon said.
10-Jan-2012 - Charles River is reportedly considering selling the business, with private equity and rival companies believed to be possible buyers.
09-Jan-2012 - Toray Industries has acquired a stake in a Japanese CMO and ingredient supplier as part of its push into life sciences.
05-Jan-2012 - UK-based biotech ValiRx has acquired a biomarkers business from Finnish preclinical CRO Pharmatest Services.
15-Dec-2011 - Charles River wants to buy drug discovery assets to meet interest in strategic outsourcing of non-regulated efficacy testing.
06-Dec-2011 - Cincinnati, US-based Schulman Associates Institutional Review Board (IRB) has bought Florida counterpart Independent Investigational Review Board (IIR) to broaden its offering for Pharmas and CROs.
29-Nov-2011 - UBC expects strategic outsourcing of outcomes and personalised medicine research to accelerate as biopharm cut fixed costs.
24-Nov-2011 - Spinning-out assets to form a CRO can help large biopharm commercialise knowledge and focus on core activities, research found.
21-Nov-2011 - SeraCare slipped into the red in the fourth quarter as loss of government business halved bioservice revenues.
16-Nov-2011 - UCB has inked a strategic deal with Parexel and PRA that an analyst believes has “very favourable” terms for the biopharm.
14-Nov-2011 - Patheon is considering buying unique drug delivery technologies to expand its development service capabilities.
10-Nov-2011 - Operating profit at PDI fell 90 per cent in the third quarter after the acquired digital communications unit again dragged on performance.
07-Nov-2011 - Catalent is considering acquisitions as it adds scale, drug delivery technologies and capacity in emerging markets.
26-Oct-2011 - Effectively outsourcing a significant portion of work will give biopharm a competitive advantage in 2020, KPMG said.
20-Oct-2011 - Quintiles has bought its way into the observational research space with the acquisition of Outcome Sciences and strengthened its market access standing with the purchase of VCG & Associates.
19-Oct-2011 - JSS Medical Research has bought Canadian assets from Venn Life Sciences as part of a joint-venture spanning North America and Europe.
10-Oct-2011 - Encorium is seeking a CRO partner or private equity buyer after the strategic outsourcing trend hit its revenues and cash reserves.
06-Oct-2011 - Akorn is to expand its CMO business into India and add sterile injectables capabilities by acquiring five manufacturing plants.
05-Oct-2011 - AmerisourceBergen will buy patient access and reimbursement support services firm TheraCom, continuing its recent run of acquisitions.
04-Oct-2011 - PPD has agreed to be acquired by two private equity firms for $3.9bn (€3.0bn) in cash.
20-Sep-2011 - PPD has named a new CEO and is now unlikely to be taken over by private equity because the deal environment has worsened, an equity analyst said.
13-Sep-2011 - Patheon is exiting semi-solids, clinical packaging and cutting facilities in response to ‘poor historical performance’.
31-Aug-2011 - inVentiv Health is looking to expand operations in Japan, China and India after completing takeovers of i3 and PharmaNet.
29-Aug-2011 - Big public CROs now generate more than half their collective revenue outside the US after triple-digit growth in recent years, a report found.